Arbutus Biopharma Corp (NASDAQ:ABUS)
| 3.07 Delayed Data As of Jan 17 |  +0.02 / +0.66%Today’s Change | 0.82 Today|||52-Week Range 4.75 | +10.43% Year-to-Date |
Latest ABUS News | Press Releases
No recent news for Arbutus Biopharma Corp.
Today’s Trading
| Previous close | 3.05 |
| Today’s open | 3.07 |
| Day’s range | 3.01 - 3.10 |
| Volume | 217,309 |
| Average volume (3 months) | 610,448 |
| Market cap | $192.5M |
Data as of 4:00pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | +22.17% |
| Earnings growth (this year) | -90.74% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -44.44% |
| P/E ratio | NM |
| Price/Sales | 35.63 |
| Price/Book | 2.32 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AFMDAffimed NV | +0.06 | +2.03% |
| OVIDOvid Therapeutics In... | +0.06 | +1.54% |
| EYPTEyePoint Pharmaceuti... | -0.01 | -0.58% |
| ARCTArcturus Therapeutic... | -0.32 | -2.63% |
Data as of 4:00pm ET, 01/17/2020
Financials
| Next reporting date | March 9, 2020 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $5.9M |
| Annual profit (last year) | -$57.1M |
| Net profit margin | -959.80% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Burnaby, British Columbia |
Forecasts
